So early 2017 will be an exciting time. Not only will we have FDA approval but the chance of a number of other regions coming online together.
§ US market entry in early 2017
- - Launch via US telehealth partner to reach millions of patients quickly
- - Potential European, Australian and Asian market entry in parallel to US
- - Deployment to low resource areas via partnerships with humanitarian organisations
Ann: Bioshares Biotech Summit Presentation-RAP.AX, page-2
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
Add to My Watchlist
What is My Watchlist?